Table 3.

Prevalence of anaemia, neutropenia and thrombocytopenia in HIV-infected women in five studies

	Anaemia			Neutropenia		Thrombocytopenia
Study (N)	Hb <12.0	Hb <11.0	Hb <10.0	WBC <2000	WBC <1000	Platelets <125 000
RWISA (710) (Rwanda)	20.3%		4.9%	4.2%	0.1%	13.5%
WIHS (2059) (North America)	37.0%		7.2%	44%	7%	14.6%
Uganda (123)		23.6%
APS (2197) (North America)	32.3%		6.8%
PEARLS (Africa, Asia and Americas)					∼15%

Uganda²⁰

APS, Anemia Prevalence Study²²; PEARLS, prospective evaluation of ART in resource limited settings²⁸; WIHS, Women's Interagency HIV Study.^{10 18}